Thermo Fisher expands India footprint with Customer Experience, Bioprocess Design Centers at Genome Valley

Written By : Ruchika Sharma Published On 2025-11-25T15:30:52+05:30 | Updated On 25 Nov 2025 3:30 PM IST

Hyderabad: Thermo Fisher Scientific has expanded its footprint in India with inauguration of two new facilities - the Customer Experience Centre (CEC) and the Bioprocess Design Center (BDC)—at Hyderabad’s Genome Valley with an investment of Rs 85-90 crores.

The expansion marks the American life sciences company's latest push to accelerate research, innovation and skill development in India.

The centres were unveiled by Telangana IT and Industries Minister D. Sridhar Babu alongside Tony Acciarito, President, Asia Pacific and Middle East, Africa Thermo Fisher Scientific, UNI reported.

The Bioprocess Design Center (BDC), a technology scale-up facility was set up in partnership with Telangana government. Other partners are Department of Biotechnology and Ministry of Science & Technology, under the Biotech Park Project.

The Center serves as a collaborative hub for scientists, entrepreneurs, and industry professionals offering hands-on training and co-development opportunities.

The center demonstrates 50 integrated workflows across 20 applications in targeted therapeutics like cell and gene therapy, mRNA, oncology, proteomics and analytical sciences featuring Thermo Fisher’s flagship technologies.

The centers will support 200 to 250 researchers and scientists annually, providing access to advanced technologies, hands-on training, and collaborative programs that accelerate innovation across bioprocessing, analytical sciences, healthcare, clean energy, and semiconductors.

Developed in collaboration with the Government of Telangana, the centers align with Telangana Life Sciences Mission to position the state as a global life sciences innovation hub.

Sridhar Babu, said, “Partnerships like this will help us achieve our target of INR 1 lakh crore in life sciences investments by 2030. These new facilities will create opportunities for collaboration and skill-building, while reinforcing our vision of making Telangana the life sciences capital of the world.”

The Bioprocess Design Center complements the CEC with bench-to-pilot scale capabilities for biologics and vaccine manufacturing. It enables rapid prototyping, process optimization and scale-up using single-use systems, supported by laboratories for cell culture, microbial fermentation, purification, and analytical testing.

Tony Acciarito said, “India’s life sciences sector is at an inflection point. These new centres reinforce our commitment to supporting the region’s growth through meaningful collaborations that help researchers and industry partners move from ideas to impact faster.”

Srinath Venkatesh, Managing Director, India and South Asia, Thermo Fisher Scientific, said, “We are committed to enabling a sustainable ecosystem that integrates talent, infrastructure, and cutting-edge technology, strengthening India’s position on the global biopharma and life sciences stage. Expanding our capability footprint through these centers demonstrate our vision to be the preferred partner for innovation, development, and manufacturing within the country.”

thermo fisher scientificD Sridhar Babu

Source : with inputs

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751